title: [Suppression of endotoxic shock by macrolide derivative, EM900, and the mechanism involved in the process].
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Inoue
authors.forename: Sachiko
authors.initials: S
authors.lastname: Watanabe
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Ideue
authors.forename: Toshiaki
authors.initials: T
authors.lastname: Sunazuka
authors.forename: Satoshi
authors.initials: S
authors.lastname: Omura
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Kumazawa
mesh_terms: D000818:Animals; D016207:Cytokines / Q000096:biosynthesis; D004917:Erythromycin / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D008070:Lipopolysaccharides / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D012772:Shock, Septic / Q000517:prevention & control*
chemical_list: C560918:(8R,9S)-8,9-dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A; D016207:Cytokines; D008070:Lipopolysaccharides; D004917:Erythromycin